Related references
Note: Only part of the references are listed.Embracing proteins: structural themes in aptamer-protein complexes
Amy D. Gelinas et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
Nancy J. Ganson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies
Kyun Heo et al.
JOURNAL OF CONTROLLED RELEASE (2016)
An anticoagulant too good to be true for revascularisation
Freek W. A. Verheugt
LANCET (2016)
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
A. Michael Lincoff et al.
LANCET (2016)
Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation
William H. Thiel et al.
MOLECULAR THERAPY (2016)
Ten years of anti-vascular endothelial growth factor therapy
Napoleone Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Aptamers as radiopharmaceuticals for nuclear imaging and therapy
Marlies Gijs et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
Fit for the Eye: Aptamers in Ocular Disorders
Daniel W. Drolet et al.
NUCLEIC ACID THERAPEUTICS (2016)
Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant
Erin E. Soule et al.
NUCLEIC ACID THERAPEUTICS (2016)
2′Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors
Youngju Lee et al.
NUCLEIC ACID THERAPEUTICS (2016)
Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
Dan Shu et al.
ACS NANO (2015)
Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
Yeh-Hsing Lao et al.
ACS NANO (2015)
The roles of nucleolin subcellular localization in cancer
Caroline Madeleine Berger et al.
BIOCHIMIE (2015)
2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia
Mario Martinez Soldevilla et al.
BIOMATERIALS (2015)
Current approaches in SELEX: An update to aptamer selection technology
Mariia Darmostuk et al.
BIOTECHNOLOGY ADVANCES (2015)
Hi-Fi SELEX: A high-fidelity digital-PCR based therapeutic aptamer discovery platform
Eric Ouellet et al.
BIOTECHNOLOGY AND BIOENGINEERING (2015)
Cancer immunotherapy via nucleic acid aptamers
Mostafa Khedri et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates
Silvia Catuogno et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy
Chao Liang et al.
NATURE MEDICINE (2015)
Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment
Agata Levay et al.
NUCLEIC ACIDS RESEARCH (2015)
Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation
Na-Oh Yunn et al.
NUCLEIC ACIDS RESEARCH (2015)
Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discovery
Jan Hoinka et al.
NUCLEIC ACIDS RESEARCH (2015)
The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation
Liang Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Smart functional nucleic acid chimeras: Enabling tissue specific RNA targeting therapy
Lukas J. Aaldering et al.
RNA BIOLOGY (2015)
Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2
Dominik Oberthuer et al.
NATURE COMMUNICATIONS (2015)
DNA Aptamer Assembly as a Vascular Endothelial Growth Factor Receptor Agonist
Vidhya Ramaswamy et al.
NUCLEIC ACID THERAPEUTICS (2015)
Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein
Chang Ho Lee et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Emulsion PCR Significantly Improves Nonequilibrium Capillary Electrophoresis of Equilibrium Mixtures-Based Aptamer Selection: Allowing for Efficient and Rapid Selection of Aptamer to Unmodified ABH2 Protein
Roman Yufa et al.
ANALYTICAL CHEMISTRY (2015)
The therapeutic monoclonal antibody market
Dawn M. Ecker et al.
MABS (2015)
Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization
Mohammad Ali Sadiq et al.
SAUDI JOURNAL OF OPHTHALMOLOGY (2015)
Stable RNA nanoparticles as potential new generation drugs for cancer therapy
Yi Shu et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
Julia Hoellenriegel et al.
BLOOD (2014)
NOX-A12: mobilizing CLL away from home
Roberto Marasca et al.
BLOOD (2014)
Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from VISION study
David S. Boyer et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Probing the Coagulation Pathway with Aptamers Identifies Combinations that Synergistically Inhibit Blood Clot Formation
Kristin M. Bompiani et al.
CHEMISTRY & BIOLOGY (2014)
Factor IXa as a target for anticoagulation in thrombotic disorders and conditions
Dia A. Smiley et al.
DRUG DISCOVERY TODAY (2014)
Immunogenicity of therapeutic proteins: Influence of aggregation
Kirsty D. Ratanji et al.
JOURNAL OF IMMUNOTOXICOLOGY (2014)
Radiolabeling Strategies for Tumor-Targeting Proteinaceous Drugs
Grant Sugiura et al.
MOLECULES (2014)
Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats
Shie-Chau Liu et al.
NEURO-ONCOLOGY (2014)
Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study
Thomas J. Povsic et al.
EUROINTERVENTION (2014)
New Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization
Abdullah Ozer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
Jiehua Zhou et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys
Frank Schwoebel et al.
BLOOD (2013)
Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors
Eli Gilboa et al.
CLINICAL CANCER RESEARCH (2013)
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial
Thomas J. Povsic et al.
EUROPEAN HEART JOURNAL (2013)
Therapeutic RNA aptamers in clinical trials
Padma Sundaram et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
K. Ghasemi Falavarjani et al.
EYE (2013)
Functional In Vivo Delivery of Multiplexed Anti-HIV-1 siRNAs via a Chemically Synthesized Aptamer With a Sticky Bridge
Jiehua Zhou et al.
MOLECULAR THERAPY (2013)
Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
Shivi Agrawal et al.
MEDIATORS OF INFLAMMATION (2013)
Identification and Characterization of an Agonistic Aptamer Against the T Cell Costimulatory Receptor, OX40
Elizabeth D. Pratico et al.
NUCLEIC ACID THERAPEUTICS (2013)
Dimeric DNA Aptamer Complexes for High-capacity-targeted Drug Delivery Using pH-sensitive Covalent Linkages
Olcay Boyacioglu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
CD28 Aptamers as Powerful Immune Response Modulators
Fernando Pastor et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
In vivo SELEX for Identification of Brain-penetrating Aptamers
Congsheng Cheng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Methods for Evaluating Cell-Specific, Cell-Internalizing RNA Aptamers
Luiza I. Hernandez et al.
PHARMACEUTICALS (2013)
Aptamer-Based Therapeutics: New Approaches to Combat Human Viral Diseases
Ka-To Shum et al.
PHARMACEUTICALS (2013)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection
William H. Thiel et al.
PLOS ONE (2012)
Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer
Domenica Musumeci et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Cell-SELEX Technology
Shoji Ohuchi
BIORESEARCH OPEN ACCESS (2012)
A streamlined protocol for emulsion polymerase chain reaction and subsequent purification
Tatjana Schuetze et al.
ANALYTICAL BIOCHEMISTRY (2011)
Aptamer selection by high-throughput sequencing and informatic analysis
Shawn Hoon et al.
BIOTECHNIQUES (2011)
Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
Emily K. Waters et al.
BLOOD (2011)
Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy
Thomas J. Povsic et al.
EUROPEAN HEART JOURNAL (2011)
Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts
Xiaohua Ni et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers
Fernando Pastor et al.
MOLECULAR THERAPY (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Emulsion PCR: A High Efficient Way of PCR Amplification of Random DNA Libraries in Aptamer Selection
Keke Shao et al.
PLOS ONE (2011)
SUSTAINED ELEVATED INTRAOCULAR PRESSURES AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, RANIBIZUMAB, AND PEGAPTANIB
Daniel Y. Choi et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura
Petra Jilina-Stohlawetz et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Nucleotide Bias Observed with a Short SELEX RNA Aptamer Library
William H. Thiel et al.
NUCLEIC ACID THERAPEUTICS (2011)
Current Status of Vascular Endothelial Growth Factor Inhibition in Age-Related Macular Degeneration
Shaker A. Mousa et al.
BIODRUGS (2010)
Integrated microfluidic system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX)
Chao-June Huang et al.
BIOSENSORS & BIOELECTRONICS (2010)
A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent Mechanism
E. Merit Reyes-Reyes et al.
CANCER RESEARCH (2010)
Engineering Dendritic Aptamer Assemblies as Superior Inhibitors of Protein Function
Youngmi Kim et al.
CHEMISTRY-AN ASIAN JOURNAL (2010)
First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention
Mauricio G. Cohen et al.
CIRCULATION (2010)
Lipophilicity in drug discovery
Michael J. Waring
EXPERT OPINION ON DRUG DISCOVERY (2010)
Expanding the Chemistry of DNA for in Vitro Selection
Jonathan D. Vaught et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Molecular Evolution of Functional Nucleic Acids with Chemical Modifications
Masayasu Kuwahara et al.
MOLECULES (2010)
A dual-targeting PDGFR beta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo
Robert Mabry et al.
MABS (2010)
Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
Fernando Pastor et al.
NATURE (2010)
In vivo selection of tumor-targeting RNA motifs
Jing Mi et al.
NATURE CHEMICAL BIOLOGY (2010)
The emerging field of RNA nanotechnology
Peixuan Guo
NATURE NANOTECHNOLOGY (2010)
Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures
Guenter Mayer et al.
NATURE PROTOCOLS (2010)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Selection of DNA aptamers using atomic force microscopy
Yusuke Miyachi et al.
NUCLEIC ACIDS RESEARCH (2010)
Pitfalls of Cell-Systematic Evolution of Ligands by Exponential Enrichment (SELEX): Existing Dead Cells During In Vitro Selection Anticipate the Enrichment of Specific Aptamers
Meltem Avci-Adali et al.
OLIGONUCLEOTIDES (2010)
The Complement Component 5 Gene and Age-Related Macular Degeneration
Dominique C. Baas et al.
OPHTHALMOLOGY (2010)
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Larry Gold et al.
PLOS ONE (2010)
Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing
Minseon Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
RNA-Based Gene Therapy for HIV With Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
David L. DiGiusto et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease
Bernd Jilma et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Targeting cancer cells with nucleic acid aptamers
Laura Cerchia et al.
TRENDS IN BIOTECHNOLOGY (2010)
A dual function TAR Decoy serves as an anti-HIV siRNA delivery vehicle
Hoshang J. Unwalla et al.
VIROLOGY JOURNAL (2010)
The Chemical Biology of Aptamers
Guenter Mayer
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes
S. G. Sayyed et al.
DIABETOLOGIA (2009)
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Paula J. Bates et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
VEGF inhibitors for the treatment of neovascular age-related macular degeneration
Mark Rami Barakat et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
The molecular mechanisms of immunomodulation and tolerance induction to factor VIII
B. Waters et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779
J. L. Diener et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Locked nucleic acid nucleoside triphosphates and polymerases: on the way towards evolution of LNA aptamers
Rakesh N. Veedu et al.
MOLECULAR BIOSYSTEMS (2009)
Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
Sridharan Soundararajan et al.
MOLECULAR PHARMACOLOGY (2009)
A Hybrid DNA Aptamer-Dendrimer Nanomaterial for Targeted Cell Labeling
Jing Zhou et al.
MACROMOLECULAR BIOSCIENCE (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P. Dassie et al.
NATURE BIOTECHNOLOGY (2009)
Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells
Jiehua Zhou et al.
NUCLEIC ACIDS RESEARCH (2009)
Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin
Shahid M. Nimjee et al.
RNA (2009)
Late onset of Cc12 blockade with the spiegelmer mNOX-E36-3′PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice
Volha Ninichuk et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Applications of aptamers in cancer cell biologry
Joseph A. Phillips et al.
ANALYTICA CHIMICA ACTA (2008)
Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting
Marie-Sophie L. Raddatz et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
The nucleolin targeting aptamer AS1411 destabilizes bcl-2 messenger RNA in human breast cancer cells
Sridharan Soundararajan et al.
CANCER RESEARCH (2008)
Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer
Claudia M. Dollins et al.
CHEMISTRY & BIOLOGY (2008)
Cell-specific internalization study of an aptamer from whole cell selection
Zeyu Xiao et al.
CHEMISTRY-A EUROPEAN JOURNAL (2008)
Cell-Specific Induction of Apoptosis by Rationally Designed Bivalent Aptamer-siRNA Transcripts Silencing Eukaryotic Elongation Factor 2
Ulrich Wullner et al.
CURRENT CANCER DRUG TARGETS (2008)
SELEX with modified nucleotides
Anthony D. Keefe et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Cell-SELEX: Novel perspectives of aptamer-based therapeutics
Ke-Tai Guo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Multivalent 4-1BB binding aptamers costimulate CD8(+) T cells and inhibit tumor growth in mice
James O. McNamara et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy
Jiehua Zhou et al.
MOLECULAR THERAPY (2008)
First-in-human evaluation of anti-von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers
James C. Gilbert et al.
CIRCULATION (2007)
Methods for selection of aptamers to protein targets
A. V. Kulbachinskiy
BIOCHEMISTRY-MOSCOW (2007)
Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice
Onkar Kulkarni et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to Anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer
K. Eszter Borbas et al.
BIOCONJUGATE CHEMISTRY (2007)
Selection of aptamers for molecular recognition and characterization of cancer cells
Zhiwen Tang et al.
ANALYTICAL CHEMISTRY (2007)
A combined atomic force/fluorescence microscopy technique to select aptamers in a single cycle from a small pool of random oligonucleotides
Lu Peng et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2007)
Vitreous injections of pegaptanib sodium triggering allergic reactions
Andrew C. G. Steffensmeier et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals
Eric E. Swayze et al.
NUCLEIC ACIDS RESEARCH (2007)
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology - A phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity
Christopher K. Dyke et al.
CIRCULATION (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Jennifer M. Burns et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
An unnatural hydrophobic base pair system: site-specific incorporation of nucleotide analogs into DNA and RNA
Ichiro Hirao et al.
NATURE METHODS (2006)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
The crystal structure of the costimulatory OX40-OX40L complex
Deanne M. Compaan et al.
STRUCTURE (2006)
Aptamer:toxin conjugates that specifically target prostate tumor cells
Ted C. Chu et al.
CANCER RESEARCH (2006)
Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular enclothelial growth factor therapy in multiple models of ocular neovascularization
Nobuo Jo et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Selection of smart aptamers by methods of kinetic capillary electrophoresis
Andrei P. Drabovich et al.
ANALYTICAL CHEMISTRY (2006)
Selection of aptamers by systematic evolution of ligands by exponential enrichment: Addressing the polymerase chain reaction issue
MU Musheev et al.
ANALYTICA CHIMICA ACTA (2006)
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
EWM Ng et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Aptamer mediated siRNA delivery
Ted C. Chu et al.
NUCLEIC ACIDS RESEARCH (2006)
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform
Vaishali Bagalkot et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Comparison of different strategies to select aptamers against a transmembrane protein target
Carine Pestourie et al.
OLIGONUCLEOTIDES (2006)
A versatile toolbox for variable DNA functionalization at high density
S Jäger et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase
RK Mosing et al.
ANALYTICAL CHEMISTRY (2005)
Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase
L Cerchia et al.
PLOS BIOLOGY (2005)
The potential of aptamers as anticoagulants
SM Nirnjee et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2005)
Direct in vitro selection of a 2 '-O-methyl aptamer to VEGF
PE Burmeister et al.
CHEMISTRY & BIOLOGY (2005)
Pegaptanib - In exudative age-related macular degeneration
MAA Siddiqui et al.
DRUGS (2005)
Pharmacokinetics and biodistribution of novel aptamer compositions
JM Healy et al.
PHARMACEUTICAL RESEARCH (2004)
Antidote-mediated control of an anticoagulant aptamer in vivo
CP Rusconi et al.
NATURE BIOTECHNOLOGY (2004)
Nanopartide-aptamer bioconjugates: A new approach for targeting prostate cancer cells
OC Farokhzad et al.
CANCER RESEARCH (2004)
Bias and artifacts in multitemplate polymerase chain reactions (PCR)
T Kanagawa
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2003)
Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3
CHB Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
T Ganz
BLOOD (2003)
Single-molecule PCR using water-in-oil emulsion
M Nakano et al.
JOURNAL OF BIOTECHNOLOGY (2003)
A nucleolar TAR decoy inhibitor of HIV-1 replication
A Michienzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
RNA aptamers as reversible antagonists of coagulation factor IXa
CP Rusconi et al.
NATURE (2002)
Structural characterization of a 2′F-RNA aptamer that binds a HIV-1SU glycoprotein, gp120
N Sayer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Labelled oligonucleotides as radiopharmaceuticals: Pitfalls, problems and perspectives
CK Younes et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Tenascin-C aptamers are generated using tumor cells and purified protein
BJ Hicke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys
DW Drolet et al.
PHARMACEUTICAL RESEARCH (2000)
Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood
H Dougan et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
Share Paper
